Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Valion Bio, Inc. (VBIO) had Operating Cash Flow per Share of $-3.04 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-7.35M |
|
-- |
|
-- |
|
$6.42M |
|
$-6.42M |
|
$-0.63M |
|
$-7.06M |
|
$-7.06M |
|
$-7.06M |
|
$-7.06M |
|
$-7.10M |
|
$-7.06M |
|
$-6.42M |
|
$-5.33M |
|
3.38M |
|
3.38M |
|
$-2.17 |
|
$-2.17 |
|
| Balance Sheet Financials | |
$3.38M |
|
$12.34M |
|
$29.09M |
|
$32.47M |
|
$3.05M |
|
$7.39M |
|
$17.54M |
|
$20.59M |
|
$4.25M |
|
$6.18M |
|
$11.88M |
|
4.15M |
|
| Cash Flow Statement Financials | |
$-10.29M |
|
$-0.06M |
|
$0.19M |
|
$12.64M |
|
$2.48M |
|
$-10.17M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.11 |
|
-- |
|
-- |
|
0.38 |
|
0.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-166.20% |
|
-114.10% |
|
-21.73% |
|
-36.62% |
|
$2.86 |
|
$-3.06 |
|
|
Operating Cash Flow per Share |
$-3.04 |